MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 126 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,311,230 | -38.3% | 15,826 | +2.3% | 0.00% | -50.0% |
Q2 2023 | $3,748,246 | 0.0% | 15,472 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $3,748,246 | -99.7% | 15,472 | -7.0% | 0.00% | +100.0% |
Q3 2022 | $1,081,044,000 | -9.2% | 16,634 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $1,190,663,000 | -2.4% | 16,634 | +33.8% | 0.00% | 0.0% |
Q1 2022 | $1,219,631,000 | +15.8% | 12,430 | 0.0% | 0.00% | – |
Q4 2021 | $1,053,317,000 | +6.2% | 12,430 | 0.0% | 0.00% | – |
Q3 2021 | $991,789,000 | -18.1% | 12,430 | 0.0% | 0.00% | -100.0% |
Q2 2021 | $1,210,807,000 | -12.4% | 12,430 | +5.1% | 0.00% | 0.0% |
Q1 2021 | $1,382,936,000 | +28.2% | 11,823 | +21.9% | 0.00% | 0.0% |
Q4 2020 | $1,078,460,000 | -3.2% | 9,701 | +3.4% | 0.00% | 0.0% |
Q3 2020 | $1,114,162,000 | +14.2% | 9,384 | +8.9% | 0.00% | 0.0% |
Q2 2020 | $975,650,000 | +306.9% | 8,615 | +139.8% | 0.00% | – |
Q1 2020 | $239,802,000 | -62.6% | 3,592 | -48.9% | 0.00% | – |
Q4 2019 | $641,050,000 | +101.4% | 7,036 | +90.6% | 0.00% | – |
Q3 2019 | $318,324,000 | -1.3% | 3,692 | +20.0% | 0.00% | – |
Q2 2019 | $322,396,000 | -16.3% | 3,076 | 0.0% | 0.00% | – |
Q1 2019 | $385,300,000 | +22.1% | 3,076 | +9.9% | 0.00% | – |
Q4 2018 | $315,616,000 | -62.9% | 2,800 | -29.5% | 0.00% | -100.0% |
Q3 2018 | $850,738,000 | -34.5% | 3,973 | -14.5% | 0.00% | 0.0% |
Q2 2018 | $1,299,440,000 | – | 4,646 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tao Capital Management LP | 77,657 | $11,342 | 8.78% |
University of Wisconsin Foundation | 40,133 | $5,861,023 | 6.72% |
Paulson & Co. | 500,000 | $73,020,000 | 6.53% |
TCG Crossover Management, LLC | 179,917 | $26,275,079 | 3.87% |
Avoro Capital Advisors LLC | 1,555,000 | $227,092,200 | 3.54% |
Affinity Asset Advisors, LLC | 85,000 | $12,413,400 | 3.49% |
Ghost Tree Capital, LLC | 57,500 | $8,397,300 | 2.76% |
Lynwood Capital Management Inc. | 5,000 | $730,200 | 1.92% |
MPM BioImpact LLC | 40,859 | $5,967,048 | 1.59% |
Tri Locum Partners LP | 33,761 | $4,930,456 | 1.58% |